Results 121 to 130 of about 1,394,911 (165)

No increased risk of hepatic enzyme abnormalities with non-peptidic thrombopoietin receptor agonists in immune thrombocytopenia: A meta-analysis of randomized controlled trials. [PDF]

Exp Ther Med
Shen N, Wu R, Lu T, Liu S, Jiang Y, Yan J, Ning T, Dong C, Li J, Zhu S.   +9 more
europepmc   +1 more source

The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity. [PDF]

Pharmaceuticals (Basel), 2023
Hamed EM, Ibrahim ARN, Meabed MH, Khalaf AM, El Demerdash DM, Elgendy MO, Saeed H, Salem HF, Rabea H.   +8 more
europepmc   +1 more source

Effectiveness of Rituximab, Belimumab, and Thrombopoietin Receptor Agonists in Refractory Immune Thrombocytopenia Associated With Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Ohta R, Ryu Y, Ichinose K.
europepmc   +1 more source

Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus. [PDF]

Ann Hematol, 2023
Pulanić D, Bátorová A, Bodó I, Červinek L, Ionita I, Lissitchkov T, Melikyan A, Podolak-Dawidziak M.   +7 more
europepmc   +1 more source

Thrombopoietin Receptor Agonists for Thrombocytopenia in Pediatric Hematologic Malignancies. [PDF]

Pediatr Blood Cancer
Marinoff AE, Thrall A, Aaronson K, Braun BS, Castellanos M, Chu J, Hermiston M, Huang BJ, Levinson A, Southworth E, Winger BA, Olshen A, Stieglitz E.   +12 more
europepmc   +1 more source

Successful Reswitching of Thrombopoietin Receptor Agonists: Two Cases of Immune Thrombocytopenia and Severe Aplastic Anemia. [PDF]

Intern Med
Itoh K, Otsuki N, Suzuki Y, Kiriba C, Kuwata A, Tsutani H, Iwasaki H, Mitsuke Y.   +7 more
europepmc   +1 more source

Thrombopoietin Receptor Agonist Exposure in Pregnancy: Not Always Without Fetal or Obstetric Complications

Turkish Journal of Hematology
Ufuk Demirci, Mine Miskioğlu
doaj   +1 more source

Unintended First-Trimester Exposure to Two Distinct Thrombopoietin Receptor Agonists in Consecutive Pregnancies Without Maternal or Fetal Harm [PDF]

Turk J Haematol
Köseoğlu FD, Kum A.
europepmc   +1 more source

Efficacy and Thrombotic Risk of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia Secondary to Systemic Lupus and Antiphospholipid Syndrome: French Experience With 80 Patients. [PDF]

Am J Hematol
Marques C, Moulis G, Roussotte M, Bonnotte B, Viallard JF, Graveleau J, Lobbes H, Costedoat-Chalumeau N, Deroux A, Gobert D, Dossier A, Gilardin L, Lambotte O, Dufrenoy M, Mahévas M, Michel M, Sève P, Godeau B.   +17 more
europepmc   +1 more source

Impact of Primary Chronic Immune Thrombocytopenia and Thrombopoietin Receptor Agonists Treatment Instructions on Daily Living: Results of a Multinational Cross-Sectional Survey. [PDF]

Patient Prefer Adherence
Zwaginga JJ, Nagalla S, Linden M, Lindberg MH, Kruse C, Morgan M, Yssing C, Decise D, Putnik M, Rich C.   +9 more
europepmc   +1 more source